Pathway to ABSSSI Efficacy

Broad Coverage for ABSSSI: gram-positive pathogens, including MRSA, and gram-negative pathogens, including Pseudomonas aeruginosa. See full Indication

See Baxdela ABSSSI Efficacy Results

Explore ABSSSI Safety & Tolerability

See Baxdela ABSSSI Safety Profile

Dosing & Administration

See BAXDELA Dosing & Administration

Next: Introduction

BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.